They Wanted a Quick Fix for Hair Loss
The Wall Street Journal on telehealth finasteride: young men prescribed through Hims and Keeps describe sexual, anxiety and suicidal symptoms.
This is coverage by another outlet. We link to it because it reports on PFS, PSSD or PAS — the reporting and any views in it are the publisher's, not ours.
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick
As reported by The Wall Street Journal (March 13, 2025):
An in-depth article by journalist Rolfe Winkler highlights the rising number of young men who have suffered severe side effects after being prescribed finasteride through telehealth platforms like Hims and Keeps. The WSJ reports that some men experienced persistent sexual dysfunction, anxiety, and suicidal thoughts—sometimes even after stopping the medication.
The article raises concerns about how telehealth companies market finasteride aggressively online, often without disclosing side effects in ads, a regulatory loophole not applicable to pharmaceutical companies. Many patients never spoke with a doctor before receiving the drug.
Clinicians quoted in the piece warn that side effects are more common than telehealth companies suggest, and that the minimal screening process may downplay serious risks. The WSJ also notes flaws in original clinical trials and points out that regulatory bodies like the FDA and EMA have recently updated labels to reflect risks, including suicidal ideation.
This information does not replace medical advice. Talk to your doctor before you make any decision about your treatment.
570+ people have joined the registry.
Join them, then report your side effects.
- Put your condition on the record
- Be first to hear about studies you can join
- Then report your side effects to your regulator